Assotsiatsiya polimorfizma gena CYP2D6 s profilem effektivnosti i bezopasnosti galoperidola pri alkogol'noy zavisimosti
- Authors: Zastrozhin M.1,2, Ryzhikova K.1, Avdeeva O.1, Sozaeva J.1, Grishina E.1, Sychev D.1, Brune E.2, Savchenko L.1, Sannikova N.3
-
Affiliations:
- Russian Medical Academy of Postgraduate Education
- Peoples’ Friendship University of Russia
- Moscow Research and Practical Centre for Narcology
- Issue: Vol 27, No 3 (2016)
- Pages: 70-72
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116569
- ID: 116569
Cite item
Open Access
Access granted
Abstract
Keywords
Full Text
About the authors
M. Zastrozhin
Russian Medical Academy of Postgraduate Education;Peoples’ Friendship University of Russia
Email: rudnmed@yandex.ru
K. Ryzhikova
Russian Medical Academy of Postgraduate Education
Email: rudnmed@yandex.ru
O. Avdeeva
Russian Medical Academy of Postgraduate Education
Email: rudnmed@yandex.ru
J. Sozaeva
Russian Medical Academy of Postgraduate Education
Email: rudnmed@yandex.ru
E. Grishina
Russian Medical Academy of Postgraduate Education
Email: rudnmed@yandex.ru
Candidate of Medical Sciences
D. Sychev
Russian Medical Academy of Postgraduate Education
Email: rudnmed@yandex.ru
Professor
E. Brune
Peoples’ Friendship University of Russia
Email: rudnmed@yandex.ru
Professor
L. Savchenko
Russian Medical Academy of Postgraduate Education
Email: rudnmed@yandex.ru
Candidate of Medical Sciences
N. Sannikova
Moscow Research and Practical Centre for Narcology
Email: rudnmed@yandex.ru
References
- Сиволап Ю.П. Рациональные подходы к применению нейролептиков в наркологической практике // Здоровая Украина. - 2008; 7 (1): 83-4.
- Butwicka A1., Krystyna S., Retka W. et al. Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency // Eur. J. Pediatr. - 2014; 173 (12): 1639-42.
- Gasso P., Papagianni K., Bobadilla R. et al. Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers // Pharmacogenomics. - 2013; 14 (13): 1551-63.
- Van der Weide K1., van der Weide J. The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, pimozide, and risperidone in psychiatric patients // J. Clin. Psychopharmacol. - 2015; 35 (3): 228-36.
- Nakamura A1., Mihara K., Nemoto K. et al. Lack of correlation between the steady-state plasma concentrations of aripiprazole and haloperidol in Japanese patients with schizophrenia // Ther. Drug. Monit. - 2014; 36 (6): 815-8.
- Jiang X., Shen H., Yu A. Pinolinemay be used as a probe for CYP2D6 activity // Drug Metab. Dispos. - 2009; 37 (3): 443-6.
- Langaee T., Hamadeh I., Chapman A. et al. A Novel Simple Method for Determining CYP2D6 Gene Copy Number and Identifying Allele(s) with Duplication / Multiplication // PLoS One. - 2015; 10 (1): e0113808.
- Crews K., Gaedigk A., Dunnenberger H. et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype // Clin. Pharmacol. Ther. - 2012; 91 (2): 321-6.
- Кукес В.Г., Грачев С.В., Сычев Д.А. и др. Метаболизм лекарственных средств: научные основы персонализированной медицины / М.: ГЭОТАР-Медиа, 2008.
- Zanger U., Raimundo S., Eichelbaum M. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry // Naunyn Schmiedebergs Arch. Pharmacol. - 2004; 369 (1): 23-37.
Supplementary files
